TY - JOUR T1 - Inhibition of Volume-Regulated and Calcium-Activated Chloride Channels by the Antimalarial Mefloquine JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 29 LP - 36 VL - 295 IS - 1 AU - Chantal Maertens AU - Lin Wei AU - Guy Droogmans AU - Bernd Nilius Y1 - 2000/10/01 UR - http://jpet.aspetjournals.org/content/295/1/29.abstract N2 - We have used the whole-cell patch-clamp technique to study the effect of mefloquine (Lariam), a commonly used antimalarial drug, on the volume-regulated anion channel (VRAC) in cultured bovine pulmonary artery endothelial cells. We also examined its effects on other Cl− channels, i.e., the Ca2+-activated Cl− channel and the cystic fibrosis transmembrane conductance regulator, to assess the specificity of this compound for VRAC. At pH 7.4 mefloquine induced a fast and reversible block of the volume-sensitive chloride current (ICl,swell), with an IC50 value of 1.19 ± 0.07 μM. The blocking efficiency increased with increasing extracellular pH (IC50value for pH 8.8 was 0.15 ± 0.01 μM), indicating that this effect is mediated by the uncharged form of mefloquine. Ca2+-activated Cl− currents, ICl,Ca, activated by loading T84 cells via the patch pipette with 1 μM free Ca2+ also were inhibited by mefloquine (IC50 value 3.01 ± 0.17 μM at pH 7.4). The cystic fibrosis transmembrane conductance regulator channel, transiently transfected in cultured bovine pulmonary artery endothelial cells, was not affected by 10 μM of the drug. This study describes for the first time effects of mefloquine on anion channels. Our data reveal a potent block of VRAC and Ca2+-activated Cl− channel at therapeutic concentrations. These results may contribute to a better understanding of the actions and side effects of this widely used antimalarial drug. The American Society for Pharmacology and Experimental Therapeutics ER -